Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Neuromuscular blocking agent (NMBA) has been proposed by medical guidelines for early severe acute respiratory distress syndrome (ARDS) because of its survival benefits. However, new studies have provided evidence contradicting these results. METHOD: A search was performed of the Pubmed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, An Thi Nhat, Patolia, Setu, Guervilly, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986163/
https://www.ncbi.nlm.nih.gov/pubmed/32015880
http://dx.doi.org/10.1186/s40560-020-0431-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986163/
https://www.ncbi.nlm.nih.gov/pubmed/32015880
http://dx.doi.org/10.1186/s40560-020-0431-z

Ejemplares similares